Anna Ågren

951 total citations · 1 hit paper
28 papers, 718 citations indexed

About

Anna Ågren is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Anna Ågren has authored 28 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Internal Medicine. Recurrent topics in Anna Ågren's work include Platelet Disorders and Treatments (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (7 papers). Anna Ågren is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (7 papers). Anna Ågren collaborates with scholars based in Sweden, Canada and Netherlands. Anna Ågren's co-authors include Margareta Holmström, Ammar Majeed, Sam Schulman, Maria Bruzelius, Maria Magnusson, Jacob Odeberg, Roza Chaireti, Tony Frisk, David E. Schmidt and Anders Östlund and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Anna Ågren

28 papers receiving 708 citations

Hit Papers

Management of rivaroxaban- or apixaban-associated major b... 2017 2026 2020 2023 2017 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ågren Sweden 14 347 270 213 175 94 28 718
Billie L. Durn United States 11 417 1.2× 325 1.2× 152 0.7× 107 0.6× 119 1.3× 20 995
René van Oerle Netherlands 17 236 0.7× 298 1.1× 251 1.2× 431 2.5× 98 1.0× 31 936
Marisa Ninivaggi Netherlands 18 160 0.5× 216 0.8× 94 0.4× 412 2.4× 51 0.5× 49 757
Jayesh Jani United States 9 144 0.4× 245 0.9× 53 0.2× 121 0.7× 68 0.7× 15 491
Hajna Losonczy Hungary 9 324 0.9× 187 0.7× 61 0.3× 258 1.5× 38 0.4× 50 686
Alex Gatt Malta 14 146 0.4× 190 0.7× 91 0.4× 360 2.1× 107 1.1× 39 750
Yoshinobu Seki Japan 14 107 0.3× 191 0.7× 104 0.5× 371 2.1× 241 2.6× 53 756
Elias Kyriakou Greece 16 118 0.3× 101 0.4× 75 0.4× 217 1.2× 59 0.6× 35 570
Roza Chaireti Sweden 13 258 0.7× 235 0.9× 46 0.2× 240 1.4× 44 0.5× 33 553
Saartje Bloemen Netherlands 13 151 0.4× 163 0.6× 67 0.3× 203 1.2× 38 0.4× 24 437

Countries citing papers authored by Anna Ågren

Since Specialization
Citations

This map shows the geographic impact of Anna Ågren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ågren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ågren more than expected).

Fields of papers citing papers by Anna Ågren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ågren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ågren. The network helps show where Anna Ågren may publish in the future.

Co-authorship network of co-authors of Anna Ågren

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ågren. A scholar is included among the top collaborators of Anna Ågren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ågren. Anna Ågren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ząbczyk, Michał, et al.. (2024). Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis. Scandinavian Journal of Clinical and Laboratory Investigation. 84(4). 257–267. 2 indexed citations
3.
Ågren, Anna, et al.. (2024). Life-Threatening Thrombosis After Large Amounts of Nitrous Oxide Use. JACC Case Reports. 29(9). 102312–102312. 3 indexed citations
4.
Mitić, Branka, et al.. (2022). Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis system. International Urology and Nephrology. 54(10). 2695–2702. 5 indexed citations
5.
Havervall, Sebastian, Maria Magnusson, Jennie Engstrand, et al.. (2021). Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma. Scientific Reports. 11(1). 18025–18025. 48 indexed citations
6.
Ågren, Anna, et al.. (2020). Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit. Thrombosis Research. 194. 98–100. 1 indexed citations
7.
Schmidt, David E., Roza Chaireti, Maria Bruzelius, et al.. (2019). Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients. Thrombosis Research. 178. 34–40. 22 indexed citations
8.
Grosso, Giorgia, Barry Woodhams, Katarina Bremme, et al.. (2017). Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS). Thrombosis Research. 158. 168–173. 13 indexed citations
9.
Januszkiewicz, Anna, et al.. (2017). Thromboelastometry. Medicine. 96(23). e7101–e7101. 13 indexed citations
10.
Schmidt, David E., Maria Bruzelius, Ammar Majeed, et al.. (2017). Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease. Thrombosis and Haemostasis. 117(8). 1528–1533. 16 indexed citations
11.
Holmström, Margareta, David E. Schmidt, Kazuya Hosokawa, et al.. (2016). Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system. Thrombosis and Haemostasis. 117(1). 75–85. 13 indexed citations
12.
Ågren, Anna, et al.. (2016). Haemostasis monitored in stored red blood cells, plasma and platelet concentrates in the proportion of 4. Blood Coagulation & Fibrinolysis. 27(3). 334–339. 3 indexed citations
13.
Majeed, Ammar, et al.. (2015). Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves. Journal of Thrombosis and Thrombolysis. 40(4). 430–436. 7 indexed citations
14.
Januszkiewicz, Anna, et al.. (2015). The temporal pattern of postoperative coagulation status in patients undergoing major liver surgery. Thrombosis Research. 136(2). 402–407. 13 indexed citations
15.
Schmidt, David E., et al.. (2015). Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls. Thrombosis Research. 135(5). 1007–1011. 55 indexed citations
16.
Ågren, Anna, Agneta Wikman, Anders Östlund, & Gustaf Edgren. (2014). TEG® Functional Fibrinogen Analysis May Overestimate Fibrinogen Levels. Anesthesia & Analgesia. 118(5). 933–935. 36 indexed citations
17.
Svenungsson, Elisabet, Anna Ågren, Fariborz Mobarrez, et al.. (2014). Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome. Thrombosis Research. 133(5). 936–944. 20 indexed citations
18.
Ågren, Anna, Agneta Wikman, Margareta Holmström, Anders Östlund, & Gustaf Edgren. (2013). Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients – a laboratory evaluation. Scandinavian Journal of Clinical and Laboratory Investigation. 73(3). 214–220. 47 indexed citations
19.
Majeed, Ammar, et al.. (2011). Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thrombosis Research. 129(2). 146–151. 83 indexed citations
20.
Ågren, Anna, B. Wiman, & Sam Schulman. (2008). Low PAI‐1 activity in relation to inflammatory parameters, insulin profile and body mass index. Journal of Internal Medicine. 264(6). 586–592. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026